Sodium gualenate

Sodium gualenate (CAS No.: 6223-35-4) is a synthetic, water compatible azulene sulfonate and is commonly classified as a small molecule inflammation biology research reagent, representing a hydrophilic derivative of guaiazulene used to investigate mucosal injury and tissue repair associated with gastrointestinal inflammatory states in preclinical systems; available evidence indicates that it is chemically unstable under ambient solid state storage and may undergo gradual decomposition, a property that is important for experimental handling and interpretation of reproducibility, while its reported functional profile is centered on anti inflammatory and wound closure associated responses in nonclinical models rather than on a fully resolved single receptor target mechanism, with current literature generally supporting pathway level modulation of inflammatory mediator production and cellular stress responses instead of a definitively validated direct molecular target, and with quantitative potency metrics such as IC50 or EC50 not consistently established across standardized assays, activity is therefore most appropriately described as being observed across concentration windows that are typically explored in the micromolar domain in exploratory in vitro paradigms depending on cell type and endpoint design; in biomedical research and early drug discovery workflows, it is typically applied in cell based injury or inflammation models, barrier and epithelial recovery assays, and animal studies of experimentally induced gastric or duodenal mucosal damage to characterize anti inflammatory phenotypes and repair associated biology, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.